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1078–5Introduction. Subclavian to carotid transposition (SCT) is gaining importance as an adjunct for thoracic endovascular
aortic repair (TEVAR). Two different anatomical approaches are described. We reviewed our experience with both ap-
proaches to evaluate the occurrence of complications and long-term outcome.
Materials/methods.We report the outcome of 150 SCTs carried between October 1979 and April 200710/79 at 2 univer-
sity based tertiary care centers. Independent neurologic evaluation was performed.
Results. Lateral and medial approaches were used in 83 (55.4%) and 67 (44.6%) cases, respectively. The internal thoracic
artery and the thyrocervical trunk were sacrificed more frequently when the lateral approach was used (1.5% vs 39.8%;
p¼ 0.0001 and 1.5% vs 49.4%; p¼ 0.0001, respectively). The medial approach was associated with significantly less
complications (8, 11.9%, compared to 24, 28.9%, p¼ 0.012). Thirty day mortality was 0.7%. Median follow-up was
36 months (1e227), and no subclavian artery occlusions were identified.
Conclusions. SCT is a durable procedure for the management of occlusive pathologies of the proximal subclavian artery
occlusion. The medial approach is associated with significantly fewer complications.
 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Subclavian to carotid transposition (SCT),1 is an effec-
tive treatment for occlusive pathologies of the proxi-
mal subclavian artery (SA). An increasing number of
patients with thoracic aortic pathologies, such as tho-
racic aortic aneurysms or type-B dissections, are now
treated by endovascular means. Frequently aortic pa-
thology borders the left SA thereby shortening the
proximal landing zone for thoracic endovascular aor-
tic repair (TEVAR). Covering the orifice of the left SA
may be performed without immediate adverse even-
ts.2e4 However, deliberate occlusion of the left SA is
frequently associated with vertebrobasilar insuffi-
ciency or upper extremity ischemia.5e7 Left SCT al-
lows the proximal landing zone to be extended
while maintaining antegrade blood flow to the upper
extremity and the vertebral artery.sponding author. C. M. Domenig, MD, Department of Sur-
ivision of Vascular Surgery, Vienna General Hospital, Medi-
iversity Vienna, Waehringer Guertel 18-20, A-1090 Vienna,
a.
address: christoph.domenig@meduniwien.ac.at
884/000551+ 07 $34.00/0  2008 European Society for VasculaTo access the proximal (first) segment of the SA for
SCT, two different approaches are described: (i) the
lateral approach8 and (ii) the medial approach.9 The
purpose of the following study was to review our ex-
perience with SCT using both approaches, and com-
pare the occurrence of complications and long-term
outcome.Methods
Data from all patients undergoing SCT at two univer-
sity-based, tertiary care centers (theDivisions of Vascu-
lar Surgery at the Vienna General Hospital and the
Salzburg General Hospital) were entered into comput-
erized vascular registries. Demographic data, indica-
tions for surgery, procedure related details and
follow-up data were entered prospectively and ana-
lyzed in a retrospective manner. The data from all
patients undergoing SCT fromOctober 1979 until April
2007 were reviewed. The indications for SCT were:
(i) for the management of symptomatic occlusive pa-
thologies of the proximal segment of the SA, primarilyr Surgery. Published by Elsevier Ltd. All rights reserved.
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adjunct for TEVAR. Bilateral non invasive blood pres-
sure measurement of the upper extremities was per-
formed prior to surgery in all patients. All patients
undergoing SCT for symptomatic occlusion of the
SA, causing symptoms of vertebrobasilar insufficiency,
were seen by a neurologist. Color coded duplex scan-
ning was performed to assess the SA and carotid ar-
teries, flow direction in the vertebral arteries was
evaluated. Further imaging modalities included arteri-
ography, CT angiography, MR angiography, and in re-
cent years, perfusion weighted MR angiography.
Patients undergoing SCT for the management of tho-
racic aortic pathologies underwent CT angiography
as primary imaging modality.
Surgical technique
All procedures were performed under general anes-
thesia. If carotid endarterectomy (CEA)was performed
simultaneously itwas donefirst, using either a separate
incision or via a modified hockeystick incision.
SCT using the medial approach9
A transverse supraclavicular skin incision approxi-
mately 2 cm superior to the clavicle was placed medi-
ally, over both heads of the sternocleidomastoid
muscle (Fig. 1A). The platysma was divided. The
common carotid artery (CCA) and the SA were ap-
proached between the bellies of the sternocleidomas-
toid muscle. The bellies should be longitudinally
divided to create enough space for placement of
self-retaining retractors and for further dissection of
the aforementioned arteries. The entire dissection oc-
curs in the space medial to the internal jugular vein.
The vagus nerve is identified. The prescalene fat
pad and the phrenic nerve are thereby avoided. The
VAwas mobilized and attachments to the sympathetic
chain and some of its fibers may be divided. For se-
cure placement of a vascular clamp to the very prox-
imal SA it is important to completely mobilize the
SA by blunt dissection. The internal thoracic artery
(ITA) and thyrocervical-trunk (TT) may be identified.
After systemic heparinization, the proximal and distal
SA and its branches are clamped, the SA is transected
1 cm proximal to VA origin. The proximal SA stump is
carefully overseen with a monofilament suture. The
CCA was cross-clamped, an arteriotomy made poste-
riolateral, and an end-to side anastomosis with the SA
was performed using monofilament suture material.
After completion of the anastomosis and flushing
blood flow was established in the SA first. In all cases
a drain was placed to the operative field.Eur J Vasc Endovasc Surg Vol 35, May 2008SCT using the lateral approach8
A transverse supraclavicular skin incision was placed
over the lateral head of the sternocleidomastoid mus-
cle and extended laterally (Fig. 1B). The platysma, the
lateral head of the sternocleidomastoid and, if neces-
sary the omohyoid muscle were divided. The scalene
fat pad with its abundant small vessels and lym-
phatics were divided along its inferior and lateral
margins, and reflected cranially. The anterior scalene
muscle was divided, while protecting the phrenic
nerve. During this step of dissection, care must be
taken not to harm the thoracic duct (left side). After
division of the anterior scalene muscle the SA is
encountered deep to the anterior scalene muscle.
The CCA was approached using medial retraction of
the internal jugular vein. To allow easier juxtaposition
to the SA the CCA should be mobilized over a sub-
stantial distance. The remaining procedure mirrors
an SCT when a medial approach was used.Follow-up
After SCT all patients underwent independent neuro-
logical examination, ENT evaluation with laryngos-
copy to detect recurrent laryngeal nerve injuries, and
fluoroscopy to detect phrenic nerve palsies. When a
left sided SCT was performed, patients received a
high fat meal on postoperative day 3 to check for lym-
phatic leakage before the surgical drain was removed.
After discharge patients were seen every 6 months
during the first year after surgery and annually there-
after. Patients undergoing SCT for the management of
thoracic aortic pathology underwent CT angiography
every 6 months after TEVAR.
Vascular patency after SCT was assessed during
follow-up by physical examination and bilateral non
invasive blood pressure measurement of the upper
extremities. Color coded duplex scanning or axial
imaging was performed when indicated.Statistical analysis
All statistical analysis was performed using the statis-
tical software package SPSS 13.0 (SPSS Inc., Chicago,
IL). Categorical variables were compared by Chi-
Square test or Fisher’s exact test where indicated.
Continuous variables were compared using the
Student’s t-test (normally distributed). Survival rates
were calculated using the Kaplan-Meier method.
The Log-Rank test was used to compare survival
curves of different groups. For all statistical analysis
a p value< 0.05 was considered significant.10
Fig. 1. Demonstration of the medial versus lateral approach in SCT (see Methods). A: Medial approach between the heads of
the sternocleidomastoid muscle. B: Lateral approach through the lateral head of the sternocleidomastoid muscle. C: Medial
approach after completion of the anastomosis, note: minimal dissection performed, the ITA and the phrenic nerve are not
visualised. D: Lateral approach after coimpletion of the anastomosis, note: extensive mobilisation of the phrenic nerve and
the internal jugular vein (blue loop), the ITA and vertebral artery extensively dissected.
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From 1979 until 2007, 150 SCTs were performed (104,
69.4%, at Vienna General Hospital and 46, 30.6%, at
Salzburg General Hospital). A median of 4 SCTs
were performed per year (range 2e15). 124 SCTs
(82.7%) were performed for occlusive pathology of
the SA, 29 (23.4%) after failed endovascular interven-
tion. 26 SCTs (17.3%) were performed as an adjunct to
TEVAR for the management of thoracic aortic pathol-
ogies. Two of 26 SCTs (7.7%) were performed after TE-
VAR, 1 for the management of a type II endoleak, 1 for
disabling arm claudication after intentional covering
of the left SA.
We applied the medial approach in 67 patients
(44.7%), the lateral approach in 83 patients (55.3%).
Patient demographics and indications for SCT
Demographic data of patients undergoing SCT using
the medial approach and the lateral approach are de-
scribed in Table 1. There was no significant differencebetween the groups in terms of patients’ age, gender,
cardiovascular risk factors, diabetes, renal disease and
dyslipidemia. In patients operated on for occlusive
pathology and patients who had undergone prior en-
dovascular intervention for the treatment of occlusive
pathologies of the SA the medial approach was used
more frequently. In 26 patients SCT was applied as
an adjunct to TEVAR. In this subset of patients the
lateral approach was used more frequently 73.1%
(19) vs 26.9% (7), p¼ 0.045. SCT was performed
more frequently on the left side 84.7% (127), and in
this subset of patients the lateral approach was used
more frequently (59.1% (75) vs 40.9% (52), p¼ 0.031).
Procedure related details
Procedure related details are depicted in Table 2. Liga-
tion (and disconnection from the SA) of the TT and
ITAwere performed more frequently when the lateral
approach was used (49.4% vs 2.4%; p¼ 0.0001 and
39.8% vs 1.5%; p¼ 0.0001, respectively). This reflects
the need for extended dissection when the lateralEur J Vasc Endovasc Surg Vol 35, May 2008
Table 1. Comparison of patient demographics: medial vs lateral approach
Medial (n¼ 67) Lateral (n¼ 83) Total (n¼ 150) p value (c2)
Age* (mean; years) 60.9 10.8 59.6 11.0 60.2 10.9 NS**
Male gender 53% (44) 47.8% (32) 50.7% (76) NS
Smoking 37.3% (25) 72.3% (60) 56.7% (85) 0.0001
Hypertension 64.2% (43) 47% (39) 54.7% (82) 0.035
Diabetes 20.9% (14) 15.7% (13) 18% (27) NS
Dyslipidemia 58.2% (39) 56.6% (47) 57.3% (86) NS
Renal disease 7.5% (5) 6% (5) 6.7% (10) NS
CAD 29.9% (20) 43.4% (36) 37.3 (56) NS
CVD 20.9% (14) 27.7% (23) 24.7% (37) NS
PVD 22.4% (15) 31.3% (26) 27.3% (41) 0.001
pMI 7.5% (5) 9.6% (8) 8.7% (13) NS
CHF 4.5% (3) 10.8% (9) 8% (12) NS
CABG 4.5% (3) 1.2% (1) 2.7% (4) NS
Indication for OP 89.6% (60) 77.1% (64) 82.7% (124) 0.045
VB Sx 76.1% (51) 60.2% (50) 67.3% (101) 0.039
pPTA 26.9% (18) 13.3% (11) 19.3% (29) 0.036
CAD, Coronary Artery Disease; CVD, Cerebrovascular Disease; PVD, Peripheral Vascular Disease; pMI, Previous Myocardial Infarction;
CHF, Congestive Heart Failure; CABG, Coronary Artery Bypass Grafting; Indication for OP, SCT Surgery for occlusive Pathology; VB
Sx, Vertebrobasilar Symptoms; pPTA, Previous subclavian artery PTA (prior to SCT); NS, not significant.
* Patient age normally distributed.
** Student t-test.
554 C. M. Domenig et al.approach is used. There was no statistical significant
difference between groups as to the frequency of
endarterectomies of the SA performed. Simultaneous
carotid endarterectomies were more common in the
lateral group (9.6% vs 1.5%, p¼ 0.037).Postoperative complications
Postoperative complications after SCT are summa-
rized in Table 3. Postoperative complications occurred
in 32 patients (21.3%). Overall, the medial approach
was associated with significantly fewer postoperative
complications (8 (11.9%) vs 24 (28.9%), p¼ 0.012).
Nerve palsies occurred more frequently when the
lateral approach was chosen (19.3% vs 3%, p¼ 0.002).
All nerve palsies were transient and resolution of
symptoms was observed within the first 6 months
after surgery. With regard to vascular complications,
the occurrence of postoperative central neurologicalTable 2. Comparison of procedure related details: medial vs lateral
approach
Medial
(n¼ 67)
Lateral
(n¼ 83)
Total
(n¼ 150)
P value
(c2)
Ligation TT 2.4% (1) 49.4% (41) 28% (42) 0.0001
Ligation ITA 1.5% (1) 39.8% (33) 22.7% (34) 0.0001
Subclavian Artery
EA
29.9% (20) 16.9% (14) 22.7% (34) NS
Simultaneous CEA 1.5% (1) 9.6% (8) 6% (9) 0.037
Complications 11.9% (8) 28.9% (24) 21.3% (32) 0.012
Ligation TT, Ligation of the Thyrocervical Trunk; Ligation ITA, Liga-
tion of the Internal Thoracic Artery; Subclavian Artery EA, Subcla-
vian Artery Endarterectomy; Simultaneous CEA, Simultaneous
Carotid Endarterectomy; NS, not significant.
Eur J Vasc Endovasc Surg Vol 35, May 2008events and lymphatic fistulas no significant difference
between groups was observed. Postoperative compli-
cations, requiring re operation were observed in 4.5%
of patients in the medial group and 2.4% of patients
in the lateral group. Surgical reintervention was
required in 3 patients in the medial group (2 postoper-
ative hemorrhages, 1 lymphatic fistula), and in 2
patients in the lateral group (1 postoperative hemor-
rhage, 1 lymphatic fistula). In one patient an embolec-
tomy of the ipsilateral brachial artery was performed
prior to SCT, leaving a 50% stenosis at the site of the
repair. Axillary artery thrombosis was observed after
SCT, but the patient remained well with minor
symptoms.
We observed no significant difference in the occur-
rence of complications when SCTs were performed on
the left side compared with SCTs performed on the
right side 19.7% (5) vs 21.7% (25), p¼ 0.821. No signif-
icant difference was observed with regard to the
occurrence of complications after SCT was performed
for occlusion as compared to as an adjunct for TEVAR
(21% (26) vs 15.4% (4), p¼ 0.518).Long term follow up and patient survival
The median follow up was 36 months (1e227). In
35.4% of patients (53), follow up was available for lon-
ger than 5 years. All arterial reconstructions remained
patent throughout follow up. Thirty day mortality
was 0.7% (n¼ 1), one patient in the medial group suf-
fered intracranial bleeding and died on postoperative
day 3 after SCT. Patient survival after 1, 3, 5 and 10
years, was 96%, 88.8%, 79.7% and 51.3%, respectively
Table 3. Postoperative complications
Medial (n¼ 66) Lateral (n¼ 83) Total (n¼ 150) P value(c2)
Partial plexus palsy 0 4 4
Phrenic nerve palsy 0 5 5
Horner’s syndromeþRecurrent nerve palsy 0 1 1
Recurrent nerve palsy 1 4 5
Horner’s syndrome 1 2 3
Transient nerve palsy (all) (3%) 2 (19.3%) 16 (12%) 18 0.002
Hematoma 0 1 1
Postoperative hemorrhage 2 1 3
Thrombosis jugular vein ipsilateral 0 1 1
Thrombosis axillary artery ipsilateral 0 1 1
Thrombosis ICA ipsilateral 1 0 1
Vascular complications (all) (4.5%) 3 (4.8%) 4 (4.7%) 7 NS
CVA ipsilateral 1 0 1
CVA contralateral (ICH) 1 0 1
Central neurological event (3%) 2 (0%) 0 (1.4%) 2 NS
Lymphatic fistula (1.5%) 1 (4.8%) 4 (3.4%) 5 NS
Complications (all) (11.9%) 8 (28.9%) 24 (21.3%) 32 0.012
Re-OP required (4.5%) 3 (2.4%) 2 (3.3%) 5 NS
CVA ipsilateral, Cerebrovascular accident ipsilateral to the operated side; CVA contralateral (ICH), Cerebrovascular accident contralateral
to the operated side e Intracranial hemorrhage; Re-OP required, redo surgery required; NS, not significant.
555SCT: Medial vs Lateral(Fig. 2). There was no significant difference in patient
survival between patients undergoing SCT via the
medial and the lateral approaches. Patient survival
after SCT at 1, 3, 5 and 10 years, was 94.4%, 90.7%,
81.8% and 49.6% when the medial approach was
chosen compared to 97.2%, 88.3%, 79.1% and 52.8%
when the lateral approach was chosen, respectively
( p¼ 0.5004, data not shown).Discussion
The requirement for subclavian artery revasculariza-
tion following coverage of its orifice during TEVAR is
controversial.10e15 A recent report from our institution0 1 2 3 4 5 6 7 8 9 10
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Fig. 2. KaplaneMeier plot demonstrating cumulative pa-
tient survival after SCT.revealed that only 25% of patients (2 out of 8)with com-
plete occlusion of the covered LSAwere free of symp-
toms at any time throughout follow up. Two patients
underwent SCTafter TEVAR for treatment of disabling
arm ischemia and endoleak formation.7 Thus SCTis be-
coming an important procedure to expand the clinical
applicability of TEVAR. To access the proximal
segment of the SA and the CCA a medial and a lateral
approach are described.8,9 In general, SCT is associated
with excellent long term results with regard to paten-
cy16e20 and our results are in line with previously pub-
lished data. In our reported series of 150 SCTs, all
arterial reconstructions remained patent throughout
a median follow up of 3 years and both approaches
performed equally effective. Schillinger reported the
results of endovascular intervention for occlusion of
the SA in 107 individuals. Patency rates after 1, 3, and
4 yearswere 91%, 83% and 79%, respectively.21 Reliable
long-term results are not available. To date no direct
comparison between surgical and endovascular man-
agement of occlusion of the SA exists, however, long
term patency rates after SCTare superior to those of ca-
rotid subclavian bypass16,22 and considerably superior
to the results reported for endovascular interven-
tion.21,23,24 In our series patient survival at 5 years after
SCT was 80% (TEVAR patients included), therefore
a durable treatment for occlusive SA pathology should
be considered. According to previously published data
SCT is associated with a postoperative complication
rate of 10 to 20%.20,22,25 We observed postoperative
complications in 21.3%, with the exception of 1 fatal
stroke, all of the complicationswere of transient nature.Eur J Vasc Endovasc Surg Vol 35, May 2008
556 C. M. Domenig et al.The complication rate of 21.3% might appear high
however it is our approach to screen for postoperative
complications. Cina pooled data from 511 patients un-
dergoing SCT.22 Transient nerve palsies were reported
in 15.4%, compared to 12% in our patient population;
lymphatic leaks were reported in 2.4%, compared to
3.4% in our patients; central neurologic events were re-
ported in 4.4%, compared to 1.4% in our patients. In
Cinas’ review no details regarding the approach used
for SCT are given. In our experience the medial ap-
proach was associated with a significantly lower com-
plication rate when compared to the lateral approach
(11.9% vs 28.9%; p¼ 0.012), this might be explained
by the fact that dissection is needed to a lesser extent
when the medial approach is chosen. In percutaneous
intervention, most complications are transient as well,
but fatal events are reported in the 1% range too.23,24
The ITA serves as an important inflow source for
revascularization of coronary arteries,26 proximal SA
stenosis compromising inflow to the ITA is best treated
prior to coronary artery revascularization.27,28 In our
series the ITA and the TTcould be preserved to a signif-
icantly higher extent in patients undergoing SCTwhen
themedial approachwas chosen (Table 2) and SCTwas
performed in 1 patient to improve inflow to the ITA
prior to coronary artery revascularization. The ascend-
ing cervical branch of the TTcontributes to the arterial
supply of the cervical cord.29 In a report by Ramirez-
Lassepas and coworkers accidental injection of con-
trast mediumdirectly into the TTresulted in transverse
cervical myelopathy at the C-6 level.30
In conclusion, SCT is a durable procedure for the
management of the proximal SA occlusion and pro-
vides excellent long term resultswith regard topatency.
In our experience the medial approach is associated
witha significantly lowercomplication rateas compared
to the lateral approach. Preservation of side branches of
the SA is possible in most cases, which is important for
the management of ischemic heart disease and thoracic
aortic pathology. The lateral approach requires slightly
more dissection, but allows better exposure of the
proximal segment of the SA and therefore closure of
the central left SAmay be easier when SCT is performed
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